Royalty Pharma plc - Class A ordinary shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+25,598,195
Put/Call ratio
20%
SEC-reported price per share
$36.03
Number of holders
452
Value change
+$949,776,240
Number of buys
249
Open additional details 1 more signal available
Number of sells
215
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
543,437,496

Security key

G7709Q104

Report period

Q2 2025

Institutions

452

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A ordinary shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
3/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.2% 12 rows are not safely comparable across share classes. 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 9.2%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 3
MORGAN STANLEY 9.2%
BlackRock, Inc. 5.7%
GENERAL ATLANTIC, L.P. 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13D/G 13F
Company
9.2%
Reported 13D/G · 30 Jun 2025
$1,394,427,274
38,907,011 shares
$0 30 Jun 2025
BlackRock, Inc.
13D/G 13F
Company
5.7%
Reported 13D/G · 31 Dec 2024
$832,319,492
25,445,414 shares
$0 31 Dec 2024
GENERAL ATLANTIC, L.P.
13D/G 13F
Company
3.2%
Reported 13D/G · 30 Jun 2025
$510,500,301
14,243,870 shares
$0 30 Jun 2025
GG 1978 SICAF SIF S.A.
3/4/5
10%+ Owner
—
denominator unverified
$608,282,853
22,081,156 shares
— 14 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
3/4/5
10%+ Owner
—
denominator unverified
$590,239,561
21,426,170 shares
— 20 Sep 2022
Mario Germano Giuliani
3/4/5
Director, 10%+ Owner
—
denominator unverified
$96,010,741
3,485,267 shares
— 23 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
452
Shares
342,210,637
Rows available
452
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
444
Q2 2025 holders
452
Holder diff
8
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .